The chemical class designated as SNX3 Activators encompasses a diverse array of compounds that indirectly influence the activation of SNX3. These activators primarily operate by modulating various cellular signaling pathways and processes, which intersect with the functional role of SNX3 in endosomal sorting and membrane trafficking. Unlike direct activators, these compounds exert their influence on SNX3 through a cascade of cellular events initiated by their primary action on specific signaling molecules or pathways.
For instance, compounds like Lithium Chloride and Forskolin demonstrate their influence by targeting the Wnt/β-catenin and cAMP pathways, respectively. These pathways, once activated or modulated, have downstream effects that can intersect with the functional dynamics of SNX3. Similarly, inhibitors like U73122 and SB 203580, which target phospholipase C and p38 MAPK, respectively, create a cellular environment where the indirect effects on SNX3's role in endosomal trafficking and protein sorting become pronounced.
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, influencing multiple signaling pathways. This broad action can impact cellular processes associated with SNX3, particularly in the context ofprotein sorting and trafficking. | ||||||